Tesamorelin TSM20 20mg*10vials

Tesamorelin TSM20 (20mg x 10 vials) is the ultra-high concentration flagship version of the TSM series of modified GHRH analog research peptides, representing the ultimate upgrade from TSM2, TSM5, and TSM10. Based on Tesamorelin's classic optimized molecular modification framework, it retains core advantages such as enzyme resistance, stable GH/IGF-1 axis activation, and unique visceral-liver dual lipid-targeting properties. With its breakthrough 20mg supersaturated high-concentration formulation and comprehensively enhanced molecular binding activity, TSM20 achieves unprecedented full-range lipolysis and extreme endocrine remodeling efficacy, completely surpassing the performance limits of traditional 10mg upper-level Tesamorelin peptides. Specifically designed for exploring ultra-limit dose gradient thresholds, refractory severe visceral steatosis, metabolic reversal of end-stage fatty liver, intervention for extreme insulin resistance, and highly challenging peptide synergistic effects, it is a top-tier core research material for cutting-edge high-threshold metabolic disorder mechanisms research and preclinical projects for extreme aging endocrine intervention.

Product Functions and Research Value

In cutting-edge laboratory research, Tesamorelin TSM20 can trigger ultra-high amplitude saturated physiological pulsatile growth hormone (GH) secretion and extremely high peak upregulation of insulin-like growth factor-1 (IGF-1), thereby comprehensively activating mitochondrial deep fat oxidation and metabolism, systemic lipid transport, and adipose tissue metabolic reprogramming pathways. TSM20's efficacy far surpasses that of TSM10, achieving industry-leading superior efficacy in thoroughly clearing stubborn deep visceral fat, completely reversing end-stage liver lipid deposition, comprehensively alleviating severe adipose tissue inflammation, and radically treating extreme insulin signaling resistance. It can effectively intervene in refractory metabolic disorders that are difficult to improve with conventional medium-to-high dose regimens, including severe central obesity, advanced metabolic-related fatty liver, and refractory lipid metabolism disorders. Simultaneously, it can provide ultra-high intensity endocrine repair and high-density lean tissue proliferation regulation, maximizing the physiological anti-aging and body composition remodeling potential of modified GHRH peptides. TSM20 strictly adheres to the natural physiological pulsed activation logic, avoiding feedback inhibition and long-term receptor desensitization even under ultra-high concentration, long-term intervention, thus maintaining ultra-stable endocrine homeostasis. TSM20 is perfectly suited for cutting-edge extreme mechanism research, ultra-high dose gradient threshold screening, and validation of highly complex complex peptide protocols. It provides ultra-high discrimination, full saturation, and authoritative extreme experimental data for in-depth exploration of endocrine intervention mechanisms in refractory metabolic syndrome and extreme aging.

Core Product Advantages

1. TSM20 Ultra-High Concentration Flagship Product: The highest-specification extreme product in the TSM series, breaking through the traditional 10mg concentration limit. With comprehensively enhanced molecular target affinity and pathway activation efficiency, it achieves the ultimate intervention performance of modified Tesamorelin peptides, specifically designed for high-threshold extreme scientific research.

2. Ultimate Visceral and Liver Lipid Clearance: Building upon the superior efficacy of TSM10, it further maximizes deep lipid pathway activation, achieving complete clearance of stubborn visceral fat and end-stage liver lipid deposits. It completely fills the research gap in interventions for refractory and severe metabolic disorders that traditional formulations cannot cover. 3. Enhanced ultra-stable modified molecular structure: Upgraded and optimized structural modification technology endows it with superior anti-degradation and anti-metabolic stability. It supports ultra-high-intensity, long-term chronic extreme metabolic interventions, outputting ultra-continuous, stable, high-amplitude metabolic regulatory signals, without hormonal fluctuations or endocrine interference, ensuring the ultimate stability of challenging long-term experimental data. 4. 20mg supersaturated extreme specification: The concentration and efficacy are twice that of TSM10, four times that of TSM5, and ten times that of TSM2. It is an exclusive ultra-high dose extreme research specification, perfectly suited for research scenarios involving super-gradient threshold exploration, interventions for refractory and severe metabolic diseases, and highly complex peptide synergistic effects. 5. Pharmaceutical-grade ultra-high purity premium product: Utilizing top-tier fully locked vacuum freeze-drying technology, it permanently locks in ultra-high peptide peak activity. Each batch of product undergoes comprehensive HPLC ultra-high purity testing.